Quantcast

Latest Peptides Stories

2009-10-27 09:00:00

NEW YORK, Oct. 27 /PRNewswire/ -- Life Extension® the global authority on nutrition, health and wellness, as well as a provider of scientific information on anti-aging supplements and therapies, has introduced Glutathione, Cysteine & C product formulated with 50 mg of Setria® Glutathione from Kyowa Hakko USA. Glutathione, Cysteine & C is available from Life Extension® in 100 count bottles at...

2009-10-22 08:41:00

BASKING RIDGE, N.J., Oct. 22 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today Ellen McDonald, MBA, Senior Vice President and Chief Business Officer, will be presenting at the BIO Investor Forum at the Palace Hotel in San Francisco, California at 2:00 PM (PDT) on Thursday, October 29, 2009. Ms. McDonald's presentation will include an overview of the Company's pipeline with emphasis on...

2009-10-20 09:30:00

NEW YORK, Oct. 20 /PRNewswire/ -- Code Blue, billed as the world's first complete recovery drink designed to help the body combat dehydration, replenish vital nutrients, remove harmful toxins and reduce inflammation, has been introduced using Sustamine(TM), L-Alanyl-L-Glutamine from Kyowa Hakko USA in the formulation. Designed by beverage scientists to revive the body, the all natural powerful ingredients in Code Blue allow you to feel better faster by helping the body combat...

2009-10-07 17:29:00

BOULDER, Colo., Oct. 7 /PRNewswire/ -- Waleed Danho, Ph.D., Distinguished Research Leader at Roche was honored last week as the 2009 recipient of the Meienhofer Award for excellence in peptide chemistry at the international peptide symposium, RCCPS (http://www.rochecolorado.com/PeptideSymp09/). Hosted by Roche Colorado, the company's peptide manufacturing facility in Boulder, RCCPS is the only global conference exclusively dedicated to peptides. For Danho, who has a world-wide reputation...

2009-10-05 07:30:00

BASKING RIDGE, N.J., Oct. 5 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that David J. Mazzo, Ph.D., President and Chief Executive Officer, will be presenting at the Japan Biopharma Conference 2009 at the Conrad Hotel in Tokyo, Japan. Dr. Mazzo's presentation is scheduled for 2:40pm (GMT +9:00) on October 6, 2009. The Conference brings together premier biotechnology companies...

2009-10-04 15:00:11

Imagine a surgical patient on a blood-thinning drug who starts bleeding more than expected, and an antidote that works immediately "“ because the blood thinner and antidote were designed to work together. Researchers at Duke University Medical Center have engineered a way to do this for an entire, versatile class of drugs called aptamers and published their findings in Nature Medicine. "With any anticoagulant, you are trying to reduce your chances of having clotting because it can lead...

2009-09-17 19:54:00

BASKING RIDGE, N.J., Sept. 17 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that the European Patent Office (EPO) has notified the Company of its intent to grant a patent with claims directed to oligonucleotide modulators of blood coagulation factor aptamers in EP 1401853. This new patent grant in the Company's portfolio extends the scope and breadth of Regado's intellectual...

2009-09-15 15:05:00

PALO ALTO, Calif., Sept. 15 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK) today announced that company management will provide a corporate overview at the UBS Global Life Sciences Conference in New York City on Tuesday, September 22, 2009 at 11:30 a.m. Eastern time (8:30 a.m. Pacific time). A live and archived webcast of the presentation will be available on the Telik website, www.telik.com. Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on...

2009-09-09 11:35:00

MATTHEWS, N.C., Sept. 9 /PRNewswire/ -- CEM Corporation, a leading global provider of microwave laboratory instrumentation, is pleased to announce that its fourth US patent covering microwave-assisted peptide synthesis (US 7,582,728) was issued on September 1, 2009. The patent contains broad claims regarding the process of using microwave energy to accelerate two key steps in performing almost all solid phase peptide synthesis, deprotection and coupling. In addition, the Company's third...

2009-09-04 07:30:00

BASKING RIDGE, N.J., Sept. 4 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that Ellen McDonald, MBA, Senior Vice President and Chief Business Officer, will be presenting at the Thomas Weisel Partners Healthcare Conference 2009 in Boston, MA at 9:45 AM on Friday, September 11, 2009 (EDT). Ms. McDonald's presentation will include an overview of the Company's pipeline with emphasis...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related